Careteq Ltd. (CTQ) AI Stock Analysis

• Market Cap: N/A
• Dividend Yield: N/A
• Average Volume (3M): 84.31K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.93
• Revenue Growth: 5.42%
• EPS Growth: 97.46%
• Country: AU
• Employees: 24
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Healthcare Information Services
• EPS (TTM): 0.00
• Shares Outstanding: 237,118,710
• 10 Day Avg. Volume: 0
• 30 Day Avg. Volume: 84,309
• PEG Ratio: 0.54
• Price to Book (P/B): 2.61
• Price to Sales (P/S): 0.52
• P/FCF Ratio: -4.93
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): <0.01
• Revenue Forecast (FY): AU$24.50M

• Rating: 41 Neutral
• Price Target: AU$0.01 ▲(0.00% Upside)

Careteq Ltd. faces significant financial challenges, with high leverage and negative cash flows being the most impactful factors. Technical indicators suggest weak momentum, and valuation metrics are unattractive due to ongoing losses. The company needs to improve financial stability and profitability to enhance its stock attractiveness.

Positive Factors

Revenue Growth

The consistent revenue growth reflects Careteq's ability to expand its market reach and enhance product adoption, which is crucial for long-term success in the competitive healthcare technology sector.

Innovative Product Offering

Careteq's focus on digital health products like smart monitoring and telehealth services positions it well to capitalize on growing demand for advanced healthcare solutions, supporting sustainable growth.

Strategic Partnerships

By forming strategic partnerships with healthcare institutions and tech companies, Careteq can enhance its product offerings and expand its market presence, supporting long-term revenue growth and competitive positioning.

Negative Factors

High Leverage

High leverage can strain financial flexibility and increase risk, potentially impacting Careteq's ability to invest in growth opportunities or weather economic downturns, posing a long-term financial challenge.

Negative Cash Flow

Negative cash flow metrics highlight inefficiencies in cash generation, which could hinder Careteq's ability to sustain operations and invest in future growth, affecting its long-term financial health.

Profitability Concerns

Ongoing profitability challenges, as indicated by negative margins, suggest difficulties in cost management or pricing strategy, potentially impacting Careteq's ability to achieve sustainable financial performance.

Careteq Ltd. Business Overview & Revenue Model

Company Description

Careteq Limited, a health-tech company, provides software as a service (SaaS)-based assistive living technology and services that focuses on meeting the needs in the health, aged, and home care sectors worldwide. The company develops and commercializes a suite of products that sit on its proprietary SaaS based assistive living technology platform for use by the elderly, disabled, and vulnerable individuals. It also offers medication management services, which include expert geriatric clinical pharmacy decision support services to general practitioners. The company was founded in 2016 and is based in Melbourne, Australia.

How the Company Makes Money

Careteq Ltd. generates revenue through multiple streams, including the sale of software licenses for its digital health platforms, subscription fees for ongoing services such as telemedicine and patient monitoring, and the sale of proprietary medical devices. The company also partners with healthcare institutions and insurance providers to integrate its solutions into existing systems, which provides additional revenue through service agreements and training programs. Moreover, Careteq Ltd. benefits from government grants and funding aimed at promoting digital health initiatives, further enhancing its financial sustainability.

Careteq Ltd. Financial Statement Overview

Summary

Careteq Ltd. demonstrates revenue growth but struggles with profitability and cash flow management. High leverage and negative equity returns pose financial risks, while negative cash flow metrics indicate challenges in sustaining operations.

Income Statement

Careteq Ltd. shows a mixed performance in its income statement. The company has achieved revenue growth, with a 7.72% increase in the latest year, indicating a positive trajectory. However, profitability remains a concern, as evidenced by negative net profit margins and EBIT margins. The gross profit margin has significantly decreased from the previous year, reflecting challenges in cost management or pricing strategy.

Balance Sheet

The balance sheet reveals a high debt-to-equity ratio of 1.56, indicating significant leverage, which could pose financial risks. The return on equity is negative, reflecting ongoing losses. The equity ratio is relatively low, suggesting limited financial stability. These factors highlight potential risks in the company's financial structure.

Cash Flow

Careteq Ltd. faces challenges in cash flow management, with negative operating and free cash flows. The free cash flow growth rate is negative, indicating deteriorating cash generation capabilities. The operating cash flow to net income ratio is also negative, suggesting inefficiencies in converting income into cash.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	7.62M	7.62M	7.23M	4.98M	4.43M	735.44K
Gross Profit	1.50M	1.50M	6.74M	-2.44M	4.14M	-2.03M
EBITDA	275.62K	275.62K	-826.62K	-2.65M	-5.90M	-5.06M
Net Income	-72.20K	-72.20K	-2.67M	-4.33M	-5.25M	-5.23M
Balance Sheet
Total Assets	5.94M	5.94M	6.82M	7.57M	8.02M	12.23M
Cash, Cash Equivalents and Short-Term Investments	1.05M	1.05M	1.25M	1.85M	4.50M	8.90M
Total Debt	2.37M	2.37M	192.98K	961.96K	0.00	75.28K
Total Liabilities	4.42M	4.42M	3.30M	4.02M	1.72M	2.61M
Stockholders Equity	1.52M	1.52M	1.97M	2.14M	6.30M	9.61M
Cash Flow
Free Cash Flow	-804.93K	-804.93K	-2.59M	-3.42M	-4.54M	-1.52M
Operating Cash Flow	-732.06K	-732.06K	-1.30M	-2.53M	-4.52M	-1.50M
Investing Cash Flow	119.16K	119.16K	-570.80K	-799.63K	-256.83K	-23.21K
Financing Cash Flow	370.14K	400.96K	1.27M	687.55K	8.81M	1.50M

Careteq Ltd. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.01
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:CTQ, the sentiment is Negative. The current price of 0.01 is below the 20-day moving average (MA) of 0.01, below the 50-day MA of 0.01, and below the 200-day MA of 0.01, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 36.83 is Neutral, neither overbought nor oversold. The STOCH value of 33.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:CTQ.

Careteq Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
ICR	44 Neutral	AU$14.30M	-4.79	―	―	241.34%	44.19%
SHG	43 Neutral	AU$83.20M	-11.67	―	―	―	―
PCK	42 Neutral	AU$55.39M	-6.06	-8647.54%	―	25.98%	22.10%
CTQ	41 Neutral	―	-36.67	3.02%	―	5.42%	97.46%
GLH	41 Neutral	AU$4.23M	-4.83	―	―	-9.90%	34.07%

Careteq Ltd. Corporate Events

Careteq Options Lapse, Trimming Potential Equity Dilution

Careteq Ltd has announced the expiry of three series of listed options on the ASX, each with different exercise prices and all lapsing unexercised on 22 December 2025. The cessation of these 3,936,513 options, which expired out of the money, marginally simplifies the company’s capital structure by reducing the pool of potential future equity dilution for existing shareholders.

The most recent analyst rating on (AU:CTQ) stock is a Hold with a A$0.01 price target. To see the full list of analyst forecasts on Careteq Ltd. stock, see the AU:CTQ Stock Forecast page.

Careteq Limited Announces Successful AGM Results

Careteq Limited announced that all resolutions were passed at its 2025 Annual General Meeting. This outcome reflects positively on the company’s governance and may strengthen its position in the healthtech industry, potentially benefiting stakeholders by reinforcing confidence in its strategic direction.

The most recent analyst rating on (AU:CTQ) stock is a Hold with a A$0.01 price target. To see the full list of analyst forecasts on Careteq Ltd. stock, see the AU:CTQ Stock Forecast page.

Careteq Updates Q1 FY26 Appendix 4C for Transparency

Careteq Limited has amended its Q1 FY26 Appendix 4C to include previously omitted details about its financing facilities, specifically loan agreements with directors and outstanding convertible notes. The company emphasizes its commitment to accurate and timely market disclosures, reflecting its current financing structure and maintaining transparency with stakeholders.

Careteq Limited Reports Q1 FY26 Growth and Strategic Developments

Careteq Limited has reported its Q1 FY26 activities, highlighting growth in its Embedded Health Solutions (EHS) with facilities under contract nearing 600 and aged-care beds increasing by 3% for the quarter. Despite facing operational cash outflows and one-off costs related to an ATO R&D matter, the company remains optimistic about its sales pipeline and has engaged a specialist firm to expedite the integration of its 1-System platform, expected to recommence in Q3 FY26. This strategic move aims to enhance operational efficiencies and support continued growth.